British Gypsum will be showcasing some of its latest interior lining solutions at Healthcare Estates (8-9 October 2013, Manchester Central, Manchester). Visitors to the plaster and drylining manufacturer’s stand (BZ20) will be able to learn more about a range of products developed for the healthcare sector, including its new ACTIVair technology.
ACTIVair is a mineral additive purpose designed to help purify air in interior spaces that can be susceptible to the build-up of volatile organic compounds (VOCs). These chemicals, originating from sources such as cleaning products, paint solvents and substances in new furniture, can be harmful to health in high concentrations and have been identified as a cause of Sick Building Syndrome and other more serious illnesses. To combat this issue, British Gypsum has developed ACTIVair which absorbs and converts VOCs to prevent their re-emission into the atmosphere, helping healthcare sector specifiers achieve Building Research Establishment Environmental Assessment Method (BREEAM) air quality ratings.
Originally launched for use in the manufacturer’s Gyptone ceiling tile range in November 2012, the technology is now available in a number of British Gypsum’s plasterboard solutions.
“Air quality plays an important part in keeping us healthy and interior spaces are vulnerable to the build-up of harmful chemicals, particularly as an increasing focus on energy efficiency means buildings are becoming more airtight to reduce heat loss,” said Paul Campbell, commercial sector manager at British Gypsum. “In response, we’ve created a technology that helps improve indoor air quality, which in turn will have a positive impact on patient health and recovery.”
Now in its 11th year, Healthcare Estates is the UK’s largest trade exhibition for the healthcare sector. The show attracts professionals and specifiers responsible for designing, building, managing and maintaining public and private medical facilities nationwide.
For more information, please visit www.british-gypsum.com/activair
Leave a Reply